Wixela Inhub: payments to doctors
Payments that named Wixela Inhub as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $98K
- Providers
- 1,161
- Transactions
- 2,349
- Average per transaction
- $42
The per-transaction average — $42 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,161 providers the average total is $84, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Mylan Inc. | $62,306 | 63.9% |
| Mylan Specialty L.p. | $35,225 | 36.1% |